The Cancer

Don't Miss

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

Vital Information

Facts

Latest Articles

Lengthy Delays Seen in Important Thrombocythemia Analysis After Platelet Rise

Sufferers with important thrombocythemia confronted a mean delay of 26.5 months between their first excessive platelet rely and analysis.Sufferers skilled a big delay...

the First Step in a Mind Most cancers Journey

After surviving mind surgical procedure, I discovered readability, power, and sudden pleasure: © inventory.adobe.com.“Espresso.” This easy phrase appears so troublesome to squeak out,...

Taking the First Step within the Most cancers Journey

After mind surgical procedure for a malignant tumor, I confronted fears, discovered energy, and embraced dwelling within the second as I start therapy...

A Name to Motion for Extra Inclusive Scientific Trials in Most cancers Care

There may be an pressing want for extra inclusive and community-focused most cancers scientific trials, in keeping with Kimberly (Cary) Demirhan, a registered...

New Trials Advance Remedies for Lymphoma, Lung Most cancers and Sarcomas

New scientific trials are advancing remedies for cutaneous T-cell lymphoma, superior stable tumors, pediatric sarcomas and ALK-positive lung most cancers.Current progress in most...

Hot Topics